MERRIMACK PHARMACEUTICALS INC Income (Loss) from Continuing Operations, Per Basic Share
MERRIMACK PHARMACEUTICALS INC reported Income (Loss) from Continuing Operations, Per Basic Share of -$0.03 per share for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2024-05-15
- MERRIMACK PHARMACEUTICALS INC income (loss) from continuing operations, per basic share for the quarter ending 2024-03-31 was -$0.03.
- MERRIMACK PHARMACEUTICALS INC income (loss) from continuing operations, per basic share for the quarter ending 2023-03-31 was -$0.02.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month |
|---|---|
| 2024-03-31 | -$0.03 10-Q · filed 2024-05-15 |
| 2023-03-31 | -$0.02 10-Q · filed 2024-05-15 |